Global Yersinia Diagnostics Market, By Test Type (Stool Culture, ELISA, Radioimmunoassay, Tube Agglutination, CT Scan, Ultrasonography, Colonoscopy), Technology (DNA Probes, Immunoassay, Monoclonal Antibodies, PCR), End User (Hospital Laboratories, Public Health Laboratories, Commercial Laboratories), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The yersinia diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of in the forecast period of 2021 to 2028 and is estimated to reach USD 293.59 million by 2028. The growing adoption of novel molecular diagnostic tools will help in escalating the growth of the yersinia diagnostics market.
Yersinia is a gram positive rod-shaped bacterium belongs to the family Enterobacteriaceae. It usually causes enterocolitis, terminal iletis, acute diarrhea, mesenteric lymphadenitis, psediappendicitis, and sepsis. Pathogenic species of Yersinia include Yersinia pestis, Yersinia enterocolitica, and Yersinia pseudotuberculosis. Yersinia is a food borne bacteria that enters the human body through unhygienic, canned, and stale food. Pigs are the main animal reservoir of Yersinia, but strains are also found in rodents, dogs, cattle, rabbits, sheep, cats, and horses.
Major factors that are expected to boost the growth of the yersinia diagnostics market in the forecast period are the development in the technology, increase in the consciousness regarding health amongst people and rise in the acceptance of molecular diagnostic tools acts. Furthermore, the increase in the number of patients across the globe and the growing of the prevalence rate of yersiniosis in the advanced countries.
On the other hand, the increased competition amongst the producers of yersinia diagnostics, the inadequate funding from the government for health care expansions and the bulk purchase by several group purchasing organizations are few of the factors that estimated to impede the growth of the yersinia diagnostics market in the near future.
This yersinia diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Yersinia diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Yersinia Diagnostics Market Scope and Market Size
The yersinia diagnostics market is segmented on the basis of test type, technology and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of test type, the yersinia diagnostics market is segmented into stool culture, ELISA, radioimmunoassay, tube agglutination, CT scan, ultrasonography, colonoscopy.
- On the basis of technology, the yersinia diagnostics market is segmented into DNA probes, immunoassay, monoclonal antibodies, PCR.
- On the basis of end user, the yersinia diagnostics market is segmented into hospital laboratories, public health laboratories, and commercial laboratories.
Yersinia Diagnostics Market Country Level Analysis
The yersinia diagnostics market is analysed and market size insights and trends are provided by country, test type, technology and end user as referenced above.
The countries covered in the yersinia diagnostics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the yersinia diagnostics market due to the increase in the prevalence of the infections. Furthermore, the rise in the elderly population will further boost the growth of the yersinia diagnostics market in the region during the forecast period. Asia Pacific is projected to observe significant amount of growth in the yersinia diagnostics market due to the growing of the investments by government forms in order to improve the health care facilities. Moreover, the presence of unused prospects and increase in the incidences of infection is further anticipated to propel the growth of the yersinia diagnostics market in the region in the coming years.
The country section of the yersinia diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The yersinia diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for yersinia diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the yersinia diagnostics market. The data is available for historic period 2010-2019.
Competitive Landscape and Yersinia DiagnosticsMarket Share Analysis
The yersinia diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to yersinia diagnostics market.
The major players covered in the yersinia diagnostics market report are Thermo Fisher Scientific, Merck KGaA, BD, bioMérieux SA, Bio-Rad Laboratories Inc., ELITechGroup Inc., GlaxoSmithKline plc., Lonza, PerkinElmer Inc., QIAGEN, F. Hoffmann-La Roche Ltd, Siemens, SeraCare Life Sciences Inc.,Abbott, Gen-probe, Hologic Inc., Danaher, Robert Bosch GmbH, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.